LINC00460 promotes epithelial–mesenchymal transition in HNSCC cells via mediating the entry of PRDX1 into the nucleus and has been proposed as a promising prognostic predictor and a possible target for cancer treatment in HNSCC.23 Here, PRDX1 is linked to head and neck squamous cell carcinoma.